9GY-12521-69824
4 vaccinations
4 coded responses
27 check-ins
3 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 596 / MT
- Registered
- 2021-01-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-06
Dose 1 — Moderna
-
2021-01-09
Registered in v-safe
-
2021-01-09
Survey response — days 1–6 daily, dose 1MedDRA: No adverse event — Feeling: Fair · Site: Pain · Fatigue or tirednessFree text: MildMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-10
- 2021-01-11
- 2021-01-12
- 2021-01-13
- 2021-01-21
- 2021-01-27
- 2021-02-03
-
2021-02-04
Dose 2 — Moderna
-
2021-02-10
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-02-11
-
2021-02-18
Survey response — day 14, dose 2MedDRA: Carbuncle, Furuncle, Induration, Inflammation, Office visit, Pain, Skin infection — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Symptoms: Skin infections: Boil ( carbuncle) of approx seven to 14?days Presentation: ::6 cm,Painful , Inflammed,large induration:culture STAPH SPP( negative coagulase)::RX Cephalexon & TRIMETHOPRIM/SULFAMETHOXAZOLE DStimes ten Days po....,,DIAGNOSIS:FEB · Healthcare visit (other): Dermatology:Cinsukt Revisit FEB25MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-18
Report sent to call center — day 14, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-05
- 2021-08-06
-
2021-10-05
Dose 3 — Moderna
-
2021-10-24
Survey response — day 14, dose 3MedDRA: Injection site pain, Nasopharyngitis, Upper respiratory tract infection — Feeling: Good · Be unable to do your normal daily activitiesFree text: Injection site pain , two weeks duration..& concomitant Severe upper Respiratory infection ( COMMON COLD,exposed to Juveniles sneezing, etc).MedDRA releases: 2024-11 · check-in free text available
- 2021-10-26
- 2021-11-02
- 2021-11-09
- 2021-11-16
- 2022-01-04
-
2022-04-05
Dose 4 — Pfizer-BioNTech
- 2022-04-05
- 2022-04-14
- 2022-04-19
- 2022-04-26
- 2022-05-03
- 2022-05-10
- 2022-05-17
- 2022-07-05
-
2023-04-07
Survey response — 12 months, dose 4MedDRA: Arthralgia, Fatigue, Malaise, Myalgia, Pain — Feeling: Poor · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-06 | Moderna | |
| 2 | 2021-02-04 | Moderna | |
| 3 | 2021-10-05 | Moderna | No |
| 4 | 2022-04-05 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
1 wait over 3 months for a first call
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Mild
Release 4 — day 14, dose 2
Symptoms: Skin infections: Boil ( carbuncle) of approx seven to 14?days Presentation: ::6 cm,Painful , Inflammed,large induration:culture STAPH SPP( negative coagulase)::RX Cephalexon & TRIMETHOPRIM/SULFAMETHOXAZOLE DStimes ten Days po....,,DIAGNOSIS:FEB
Healthcare visit (other): Dermatology:Cinsukt Revisit FEB25
Release 10 — day 14, dose 3
Symptoms: Injection site pain , two weeks duration..& concomitant Severe upper Respiratory infection ( COMMON COLD,exposed to Juveniles sneezing, etc).
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| SD | Arthralgia | · | · | ✓ |
| SD | Carbuncle | ✓ | ✓ | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Furuncle | ✓ | ✓ | ✓ |
| SD | Induration | ✓ | ✓ | ✓ |
| SD | Inflammation | ✓ | ✓ | ✓ |
| SD | Injection site pain | · | · | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pain | ✓ | ✓ | ✓ |
| SD | Skin infection | ✓ | ✓ | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
| SRO | No adverse event | ✓ | ✓ | ✓ |
| SRO | Unevaluable event | ○ | ○ | ○ |
✓ active code · ○ coded but marked inactive · blank = not in that release